Administrative
Resolution No. (107) of 2020
Modifying
the Charges for Novel Coronavirus (COVID-19)
Laboratory
Tests Conducted by
the Dubai Health Authority[1]
________________________________
The
Director General of the Dubai Health Authority,
After perusal of:
Law No. (14) of 2009 Concerning the Pricing of Government
Services in the Emirate of Dubai and its amendments;
Law No. (32) of 2015 Concerning the Official Gazette of the
Government of Dubai;
Law No. (1) of 2016 Concerning the Financial Regulations of
the Government of Dubai;
Law No. (6) of 2018 Concerning the Dubai Health Authority
(the “DHA");
Decree No. (9) of 2012 Approving a Pricing Method for Dubai
Health Authority Services;
Decree No. (18) of 2018 Appointing the Director General of
the Dubai Health Authority;
Administrative Resolution No. (72) of 2020 Approving the Charges
for Novel Coronavirus (COVID-19) Laboratory Tests Conducted by the Dubai Health
Authority (the “Original
Resolution”); and
The Department of Finance Letter Ref.
(DOF/OUT/2020/0002187),
dated 10 September 2020,
approving the reduction of
charges for the Novel Coronavirus (COVID-19) laboratory tests previously
approved pursuant to the above-mentioned Administrative Resolution No. (72) of
2020,
Does hereby issue this Resolution.
Pursuant
to this Resolution, the charges for the Novel Coronavirus (COVID-19) laboratory
tests stated in the Schedule attached to the above-mentioned Administrative
Resolution No. (72) of 2020
are modified as set forth in the Schedule attached to this Resolution.
This
Resolution comes into force on 10 September 2020, and will be published in the
Official Gazette.
Humaid
Al Qatami
Director General
Dubai Health Authority
Issued in Dubai on 13 September 2020
Corresponding to 25 Muharram 1442 A.H.
New Charges for Novel Coronavirus (COVID-19) Laboratory
Tests
|
S.N. |
Billing
Code / Service Code |
Service
Description |
Charges
(in Dirhams) |
|
1 |
87635-1
(Used for COVID-19 test) |
Infectious
agent detection by nucleic acid (DNA or RNA); severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]),
amplified probe technique |
250.00 |
|
2 |
87635-2
(Used for Remote COVID-19 test) |
Infectious
agent detection by nucleic acid (DNA or RNA); severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]),
amplified probe technique |
250.00 |
©2020 The
Supreme Legislation Committee in the Emirate of Dubai
[1]Every effort has been made to produce an
accurate and complete English version of this legislation. However, for the
purpose of its interpretation and application, reference must be made to the
original Arabic text. In case of conflict, the Arabic text will prevail.